FIELD: medicine; pharmaceutics.
SUBSTANCE: invention relates to the field of medicine and pharmaceutics. Disclosed is the use of a pharmaceutical composition containing aprotinin as an active ingredient and excipients, as an antiviral agent for treating and preventing COVID-19.
EFFECT: invention provides high antiviral activity in the treatment and prevention of COVID-19.
4 cl, 4 ex
| Title | Year | Author | Number |
|---|---|---|---|
| PHARMACEUTICAL KIT FOR COMBINATION THERAPY OF COVID-19 (SARS-COV-2) AND METHOD OF ITS APPLICATION | 2020 |
|
RU2746161C1 |
| COVID-19 (SARS-COV-2) COMBINATION THERAPY AND TREATMENT METHOD | 2020 |
|
RU2745986C1 |
| ANTI-CORONAVIRUS AGENT FOR COVID-19 COMBINATION THERAPY (SARS-COV-2) | 2020 |
|
RU2742116C1 |
| ANTI-RNA VIRAL, INCLUDING ANTI-CORONAVIRUS AGENT - SUBSTITUTED QUINOXALINE, PHARMACEUTICAL COMPOSITION AND APPLICATIONS | 2020 |
|
RU2744429C1 |
| ANTICORONAVIRUS THERAPEUTIC AGENT - SUBSTITUTED 7-HYDROXY-3,4,12,12A-TETRAHYDRO-1H-[1,4]OXAZINO[3,4-C]PYRIDO[2,1-F][1,2,4]TRIAZINE-6,8-DIONE FOR THE PREVENTION AND TREATMENT OF COVID-19 | 2020 |
|
RU2745985C1 |
| ANTI-COVID-19 (SARS-COV-2) VIRAL PHARMACEUTICAL COMPOSITION | 2020 |
|
RU2731932C1 |
| ANTI-SARS-CoV-2-VIRAL PHARMACEUTICAL COMPOSITION AND APPLICATION THEREOF | 2020 |
|
RU2764444C1 |
| INDOLE-3-CARBOXYLIC ACID DERIVATIVE HAVING ANTIVIRAL ACTIVITY ON SARS-CoV-2 | 2022 |
|
RU2820633C1 |
| ACTIVE COMPONENT, PHARMACEUTICAL COMPOSITION AND DRUG PREPARATION FOR HIV AND AIDS THERAPY | 2019 |
|
RU2716257C1 |
| COMBINED DRUG FOR VIRAL INFECTION THERAPY | 2017 |
|
RU2662160C9 |
